Gray Television Inc. (GTN): here we go 1.00+ $ I like this short ter...

wesley_ · 2009-08-26T14:54:41.2330000Z

here we go 1.00+ $ I like this short term gainers :-) $$$

Play Episode

6min

Proactive - Interviews for investors

Immunic presents at ACTRIMS forum as it awaits key CALLIPER MS trial data

Immunic Therapeutics chief medical officer Dr Andreas Muehler talked with Proactive's Stephen Gunnion about the company's strong presence at the 10th annual ACTRIMS Forum, where it presented two key posters on multiple sclerosis (MS). He highlighted that Immunic’s investigational drug, vidofludimus calcium, has potential neuroprotective properties that may benefit both relapsing and progressive MS patients. One of the posters examined baseline characteristics of past progressive MS trials and contrasted them with Immunic’s CALLIPER trial, designed for non-relapsing patients with minimal inflammatory activity. The second poster explored preclinical data on the drug’s mechanism of action, emphasizing its potential to target activated microglia and support neuron survival. Muehler noted significant engagement from the MS community at ACTRIMS, with many keenly anticipating the CALLIPER trial’s readout in April. “It’s really one of the very few late-stage drugs with a potential neuroprotective effect,” he said, adding that the data could provide new hope for progressive MS patients who currently have limited treatment options. Stay tuned for more updates on Immunic’s progress. For more interviews, subscribe to Proactive’s YouTube channel, like this video, and turn on notifications! #ImmunicTherapeutics #MSResearch #Neuroprotection #CALLIPERTrial #MultipleSclerosis #Biotech #DrugDevelopment #ClinicalTrials #MedicalBreakthrough #ACTRIMS

Proactive - Interviews for investors

Lisata Therapeutics expands drug discovery with GATC AI collaboration

Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo talked with Proactive about the company’s strategic collaboration with GATC Health, a leader in artificial intelligence-driven drug discovery. Mazzo explained that GATC’s technology, which is recognized by Lloyd’s of London for clinical trial risk assessment, will be used to analyze Lisata’s lead candidate, certepetide, and identify potential new drug combinations. Mazzo highlighted that this collaboration will optimize Lisata’s ongoing cancer research, including trials in pancreatic ductal adenocarcinoma, cholangiocarcinoma, and other cancers. He noted that GATC’s AI technology can perform billions of simulations rapidly, potentially reducing the cost and risk of drug development. Discussing Lisata’s 2025 outlook, Mazzo described it as a "data-rich year," with upcoming results from the ASCEND trial and other studies. He emphasized the potential for certepetide in combination with immunotherapy and the company’s ongoing discussions with regulatory agencies and potential partners. To watch more interviews like this, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe, and enable notifications for future updates. #LisataTherapeutics #Biotech #CancerResearch #AIinHealthcare #DrugDevelopment #ClinicalTrials #GATCHealth #Pharma #Oncology #Investing

Proactive - Interviews for investors

Vinyl Group CEO on expansion, profitability & strategy after H1 revenue soars 770%

Vinyl Group Ltd CEO Josh Simons talked with Proactive's Jonathan Jackson about the company's strong financial growth, recent acquisitions, and future expansion plans. The company recently reported a 770.2% revenue increase in its latest half-year results. Simons highlighted the annual revenue run rate growth from $2 million to $20 million, emphasising that Vinyl Group is executing its aggressive acquisition strategy while optimising operations for profitability. A key topic of discussion was the acquisition of Concrete Playground, a move that expands Vinyl Group’s media and advertising reach. Simons explained that integrating Concrete Playground into the company’s existing infrastructure creates significant cross-selling opportunities whilst also strengthening Vinyl Group's market position. Looking ahead, Simons discussed the global expansion potential of Vinyl Group’s tech platforms. He noted that for the first time, the company’s tech segment outperformed its media business in revenue, signaling a shift toward scalable, international growth. “The pathway we’re on is clear—we’re optimising, moving towards profitability, and laying the groundwork for further expansion,” Simons said. For more interviews and updates, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe, and turn on notifications for future updates. #VinylGroup #Music #MusicIndustry #JoshSimons #BusinessGrowth #TechExpansion #InvestorNews #MusicTech #ProactiveInvestors

Proactive - Interviews for investors

Nostra Terra Oil and Gas completes fundraise as it advances Pine Mills workovers

Nostra Terra Oil and Gas Company PLC (AIM:NTOG, OTC:NTOGF) CEO Paul Welch talked with Proactive's Stephen Gunnion about the company’s latest developments, including its recently completed £500,000 fundraise. The funds will be used to complete the phase two workover program at Pine Mills, addressing well integrity issues and optimising oil production. Welch highlighted that the company is currently profitable at existing oil prices and remains focused on maximising the potential of Pine Mills before exploring new opportunities. He also discussed the ongoing technical evaluation of the Fouke three location with their partner, with further updates expected. Welch noted that the water flood program, which restarted in September, has exceeded expectations, leading to increased oil production. As a result, part of the funds raised will go towards upgrading two pumping units to support higher output. Looking ahead, Welch emphasised that Nostra Terra is focused on maintaining a solid, profitable base while evaluating further growth opportunities. He pointed out that the company has additional behind-pipe opportunities and untapped potential within Pine Mills, positioning it for continued success. For more updates on Nostra Terra Oil and Gas, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for more interviews and insights. #NostraTerra #OilAndGas #EnergyInvesting #OilProduction #Fundraising #Investing #StockMarket #EnergySector #OilIndustry #TexasOil

Followers	115
Posts	14170
Boards Moderated	2
Alias Born	10/24/2007

Volume:	1,709,194
Day Range:	4.19 - 4.375
Bid:
Ask:
Last Trade Time:	7:00:00 PM EDT
Total Trades:	8,781

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

GTN Detailed Quote

Recent GTN News

More GTN News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent GTN News

Go Ad-Free